Different Aspects of Self-Reported Quality of Life in 450 German Melanoma Survivors

The present study was aimed at assessing quality of life (QoL) in a total of 450 melanoma patients who filled out the EORTC QLQ-C30 (Q1; 15 months post diagnosis) as part of the OVIS Study. Follow-up questionnaires (Q2) were administered two years after Q1. The analyses presented herein were based o...

Full description

Bibliographic Details
Main Authors: Eckhard W. Breitbart, Alexander Katalinic, Ron Pritzkuleit, Sandra Nolte, Annika Waldmann
Format: Article
Language:English
Published: MDPI AG 2011-05-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/3/2/2316/
_version_ 1797724914025758720
author Eckhard W. Breitbart
Alexander Katalinic
Ron Pritzkuleit
Sandra Nolte
Annika Waldmann
author_facet Eckhard W. Breitbart
Alexander Katalinic
Ron Pritzkuleit
Sandra Nolte
Annika Waldmann
author_sort Eckhard W. Breitbart
collection DOAJ
description The present study was aimed at assessing quality of life (QoL) in a total of 450 melanoma patients who filled out the EORTC QLQ-C30 (Q1; 15 months post diagnosis) as part of the OVIS Study. Follow-up questionnaires (Q2) were administered two years after Q1. The analyses presented herein were based on the following assumptions: QoL of melanoma patients is worse than that of a German reference population. Further, both tumor location and tumor stage have an influence on self-reported QoL, with patients with tumors located on face, head, neck, and advanced tumor stage (T3/T4) reporting the worst QoL levels. Finally, patients’ QoL improves over time based on the theory of disease adaptation. In contrast to the above assumptions, with the exception of global health/QoL scores, differences between OVIS and the reference population were below the minimal clinical important difference of ten points. Furthermore, no clinically meaningful differences were found between patients after stratifying our data by tumor location and tumor stage. Finally, no clinically relevant changes were seen between Q1 and Q2 across all scales of the EORTC QLQ-C30. However, when data were stratified by patients with stable disease versus those with progression, clinically relevant differences were found between Q1 and Q2 predominantly in women in the latter group regarding emotional function, insomnia, dyspnoea, and fatigue. The lack of clinically meaningful differences across strata (tumor location; tumor stage), time, and patients compared to a reference population is surprising. However, it is possible that the instrument used, a generic QoL instrument, is generally not sensitive enough to detect differences in melanoma patients. Our findings may further be explained by the fact that all patients included in our sample had been diagnosed well before Q1, i.e., main illness adaptation processes may have occurred before study entry.
first_indexed 2024-03-12T10:23:45Z
format Article
id doaj.art-73f66db56bc744e489a0f3ca77fa4d0b
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T10:23:45Z
publishDate 2011-05-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-73f66db56bc744e489a0f3ca77fa4d0b2023-09-02T09:56:12ZengMDPI AGCancers2072-66942011-05-01322316233210.3390/cancers3022316Different Aspects of Self-Reported Quality of Life in 450 German Melanoma SurvivorsEckhard W. BreitbartAlexander KatalinicRon PritzkuleitSandra NolteAnnika WaldmannThe present study was aimed at assessing quality of life (QoL) in a total of 450 melanoma patients who filled out the EORTC QLQ-C30 (Q1; 15 months post diagnosis) as part of the OVIS Study. Follow-up questionnaires (Q2) were administered two years after Q1. The analyses presented herein were based on the following assumptions: QoL of melanoma patients is worse than that of a German reference population. Further, both tumor location and tumor stage have an influence on self-reported QoL, with patients with tumors located on face, head, neck, and advanced tumor stage (T3/T4) reporting the worst QoL levels. Finally, patients’ QoL improves over time based on the theory of disease adaptation. In contrast to the above assumptions, with the exception of global health/QoL scores, differences between OVIS and the reference population were below the minimal clinical important difference of ten points. Furthermore, no clinically meaningful differences were found between patients after stratifying our data by tumor location and tumor stage. Finally, no clinically relevant changes were seen between Q1 and Q2 across all scales of the EORTC QLQ-C30. However, when data were stratified by patients with stable disease versus those with progression, clinically relevant differences were found between Q1 and Q2 predominantly in women in the latter group regarding emotional function, insomnia, dyspnoea, and fatigue. The lack of clinically meaningful differences across strata (tumor location; tumor stage), time, and patients compared to a reference population is surprising. However, it is possible that the instrument used, a generic QoL instrument, is generally not sensitive enough to detect differences in melanoma patients. Our findings may further be explained by the fact that all patients included in our sample had been diagnosed well before Q1, i.e., main illness adaptation processes may have occurred before study entry.http://www.mdpi.com/2072-6694/3/2/2316/skin neoplasmsmelanomaquality of lifepopulation basedhealth care survey
spellingShingle Eckhard W. Breitbart
Alexander Katalinic
Ron Pritzkuleit
Sandra Nolte
Annika Waldmann
Different Aspects of Self-Reported Quality of Life in 450 German Melanoma Survivors
Cancers
skin neoplasms
melanoma
quality of life
population based
health care survey
title Different Aspects of Self-Reported Quality of Life in 450 German Melanoma Survivors
title_full Different Aspects of Self-Reported Quality of Life in 450 German Melanoma Survivors
title_fullStr Different Aspects of Self-Reported Quality of Life in 450 German Melanoma Survivors
title_full_unstemmed Different Aspects of Self-Reported Quality of Life in 450 German Melanoma Survivors
title_short Different Aspects of Self-Reported Quality of Life in 450 German Melanoma Survivors
title_sort different aspects of self reported quality of life in 450 german melanoma survivors
topic skin neoplasms
melanoma
quality of life
population based
health care survey
url http://www.mdpi.com/2072-6694/3/2/2316/
work_keys_str_mv AT eckhardwbreitbart differentaspectsofselfreportedqualityoflifein450germanmelanomasurvivors
AT alexanderkatalinic differentaspectsofselfreportedqualityoflifein450germanmelanomasurvivors
AT ronpritzkuleit differentaspectsofselfreportedqualityoflifein450germanmelanomasurvivors
AT sandranolte differentaspectsofselfreportedqualityoflifein450germanmelanomasurvivors
AT annikawaldmann differentaspectsofselfreportedqualityoflifein450germanmelanomasurvivors